Same-day imaging using small proteins: Clinical experience and translational prospects in oncology.Show others and affiliations
2018 (English)In: Journal of Nuclear Medicine, ISSN 0161-5505, E-ISSN 1535-5667, Vol. 59, no 6, p. 885-891Article in journal (Refereed) Published
Abstract [en]
Imaging of expression of therapeutic targets may enable patients' stratification for targeted treatments. The use of small radiolabeled probes based on the heavy-chain variable region of heavy-chain-only immunoglobulins or non-immunoglobulin scaffolds permits rapid localization of radiotracers in tumors and rapid clearance from normal tissues. This makes high-contrast imaging possible on the day of injection. This mini-review focuses on small proteins for radionuclide-based imaging that would allow same-day imaging, with the emphasis on clinical applications and promising preclinical developments within the field of oncology.
Place, publisher, year, edition, pages
2018. Vol. 59, no 6, p. 885-891
Keywords [en]
Animal Imaging, Molecular Imaging, Oncology: Breast, affibody, nanobody, radionuclide molecular imaging, scaffold proteins
National Category
Radiology, Nuclear Medicine and Medical Imaging
Identifiers
URN: urn:nbn:se:uu:diva-351165DOI: 10.2967/jnumed.117.199901ISI: 000435102600013PubMedID: 29545374OAI: oai:DiVA.org:uu-351165DiVA, id: diva2:1208940
Funder
Swedish Cancer SocietySwedish Research Council
Note
De 2 sista författarna delar sistaförfattarskapet.
2018-05-212018-05-212018-08-24Bibliographically approved